This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Boston Scientific Scimed, Inc.. Active years: 2020-2023.
Company Filing History:
Years Active: 2020-2023
Title: Sophia Gervasio: Innovator in Hemostasis Technology
Introduction
Sophia Gervasio is a notable inventor based in Coventry, RI (US). She has made significant contributions to the field of medical technology, particularly in the area of hemostasis. With a total of 2 patents, her work focuses on innovative solutions for treating and preventing bleeding at tissue sites.
Latest Patents
Sophia's latest patents include a chitosan powder composition designed for achieving hemostasis. This invention involves methods of applying the chitosan powder to a tissue site to effectively treat or prevent bleeding. The powder compositions may include a chitosan salt, a crosslinked chitosan, a derivatized chitosan, or a combination thereof. Additionally, her patents pertain to catheter assemblies that are preloaded with the chitosan powder composition, enabling targeted delivery to the tissue site.
Career Highlights
Sophia Gervasio is currently employed at Boston Scientific Scimed, Inc., where she continues to develop innovative medical solutions. Her work has garnered attention for its potential to improve patient outcomes in surgical and emergency settings.
Collaborations
Some of her notable coworkers include Lauren Lydecker and Gerald Fredrickson, who contribute to the collaborative environment that fosters innovation at Boston Scientific.
Conclusion
Sophia Gervasio's contributions to hemostasis technology exemplify the impact of innovative thinking in the medical field. Her patents reflect a commitment to advancing healthcare solutions that can save lives.